Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford is delighted to announce that the first collaborative research projects to be agreed by the University under the Pfizer Rare Disease Consortium have been signed.

The collaborations are the result of a strategic alliance to develop new treatments for rare diseases which was put in place by the University of Oxford, Imperial College London, University College London, King’s College London, Queen Mary University London, and Cambridge University acting through GMEC Pfizer will be collaborating with the University of Oxford in haematology and neuromuscular disorders. Michael Skynner, Head of Rare Disease Alliances, Pfizer, says “I am delighted to see concrete output from the first Pfizer Rare Disease Consortium call for proposals with GMEC, in the form of three funded research proposals at the University of Oxford. I look forward to a close scientific interaction between Oxford and Pfizer over the next three years”.

Congratulations to the successful Principal Investigators:

  • Professor Dame Kay Davies and Professor Matthew Wood from the Department of Physiology, Anatomy and Genetics.
  • Professor Alexander Drakesmith and Professor Simon Draper from the Weatherall Institute for Molecular Medicine and the Jenner Institute respectively.
  • Dr Wyatt Yue from the Structural Genomics Consortium.

We wish them good luck for their research!

Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

The brain’s one-sided teaching signals

A new study by the Lak group reveals a novel facet of dopamine signalling during visual decision making.

Fellowship awarded to Huriye Atilgan to enhance our understanding of value-based decision-making

Congratulations are in order for Postdoctoral Research Scientist Dr Huriye Atilgan who has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship funded by the Wellcome Trust.

The future of stroke treatment

A team of international collaborators including DPAG's Dr Mootaz Salman has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.

Frances Ashcroft and Denis Noble honoured by the IUPS Academic of Physiology

Professors Dame Frances Ashcroft and Denis Noble have been elected Fellows of the the International Union of Physiological Sciences (IUPS) Academy of Physiology in the inaugural year of its Fellowships.